BR9910606A - Forma farmacêutica multiparticular com liberação programada e pulsada e seu processo de preparo - Google Patents

Forma farmacêutica multiparticular com liberação programada e pulsada e seu processo de preparo

Info

Publication number
BR9910606A
BR9910606A BR9910606-0A BR9910606A BR9910606A BR 9910606 A BR9910606 A BR 9910606A BR 9910606 A BR9910606 A BR 9910606A BR 9910606 A BR9910606 A BR 9910606A
Authority
BR
Brazil
Prior art keywords
multiparticular
pulsed release
programmed
preparation process
dosage form
Prior art date
Application number
BR9910606-0A
Other languages
English (en)
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Original Assignee
Prographarm Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prographarm Lab filed Critical Prographarm Lab
Publication of BR9910606A publication Critical patent/BR9910606A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"FORMA FARMACêUTICA MULTIPARTICULAR COM LIBERAçãO PROGRAMADA E PULSADA E SEU PROCESSO DE PREPARO"<D>. A invenção refere-se a uma forma farmacêutica multiparticular com liberação retardada e pulsada, permitindo obter o começo da colocação do princípio ativo à disposição nas 4 a 8 horas, de acordo com a ingestão dessa forma farmacêutica, depois a liberação progressiva da totalidade do princípio ativo nas 8 as 20 horas seguintes, caracterizada pelo fato de ser isenta de ácido orgânico e de ela se apresentar sob a forma de esferóides medicamentosos constituídos de um suporte esférico neutro que comporta um primeiro revestimento à base de uma mistura de pelo menos um polímero hidrossolúvel e de pelo menos um polímero não hidrossolúvel no meio do qual são uniformemente repartidas partículas constitutivas de um princípio ativo, o conjunto comportando um segundo revestimento à base de pelo menos dois polímeros pH independentes, apresentando graus de permeabilidade face aos meios gástrico e intestinal diferentes, eventualmente de pelo menos um polímero pH dependente, de pelo menos um plastificante e de pelo menos uma carga inerte uniformemente repartida nesse revestimento.
BR9910606-0A 1998-05-20 1999-05-20 Forma farmacêutica multiparticular com liberação programada e pulsada e seu processo de preparo BR9910606A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (1)

Publication Number Publication Date
BR9910606A true BR9910606A (pt) 2001-10-02

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910606-0A BR9910606A (pt) 1998-05-20 1999-05-20 Forma farmacêutica multiparticular com liberação programada e pulsada e seu processo de preparo

Country Status (25)

Country Link
EP (1) EP1077687B1 (pt)
JP (1) JP2002515423A (pt)
KR (1) KR100583065B1 (pt)
CN (1) CN1186014C (pt)
AT (1) ATE214598T1 (pt)
AU (1) AU758299B2 (pt)
BG (1) BG64764B1 (pt)
BR (1) BR9910606A (pt)
CA (1) CA2333188C (pt)
DE (1) DE69901062T2 (pt)
DK (1) DK1077687T3 (pt)
ES (1) ES2173739T3 (pt)
FR (1) FR2778848B1 (pt)
GE (1) GEP20022750B (pt)
HK (1) HK1033271A1 (pt)
HU (1) HU224193B1 (pt)
IL (1) IL139774A (pt)
MX (1) MXPA00011364A (pt)
NO (1) NO330501B1 (pt)
NZ (1) NZ508392A (pt)
PL (1) PL192950B1 (pt)
PT (1) PT1077687E (pt)
TR (1) TR200100107T2 (pt)
WO (1) WO1999059557A1 (pt)
ZA (1) ZA200006768B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
CN1305371A (zh) 2001-07-25
GEP20022750B (en) 2002-08-26
BG104963A (en) 2001-07-31
AU3830299A (en) 1999-12-06
PT1077687E (pt) 2002-09-30
PL192950B1 (pl) 2006-12-29
NZ508392A (en) 2002-09-27
FR2778848A1 (fr) 1999-11-26
ATE214598T1 (de) 2002-04-15
TR200100107T2 (tr) 2001-06-21
CA2333188A1 (fr) 1999-11-25
DK1077687T3 (da) 2002-06-17
DE69901062T2 (de) 2002-10-31
KR20010052370A (ko) 2001-06-25
AU758299B2 (en) 2003-03-20
EP1077687A1 (fr) 2001-02-28
HUP0102027A2 (hu) 2002-03-28
MXPA00011364A (es) 2008-09-09
BG64764B1 (bg) 2006-03-31
WO1999059557A1 (fr) 1999-11-25
ES2173739T3 (es) 2002-10-16
IL139774A0 (en) 2002-02-10
NO330501B1 (no) 2011-05-02
NO20005838D0 (no) 2000-11-17
HUP0102027A3 (en) 2002-12-28
HU224193B1 (hu) 2005-06-28
EP1077687B1 (fr) 2002-03-20
PL344314A1 (en) 2001-10-22
DE69901062D1 (de) 2002-04-25
FR2778848B1 (fr) 2001-11-23
NO20005838L (no) 2001-01-10
CA2333188C (fr) 2010-07-06
IL139774A (en) 2005-09-25
JP2002515423A (ja) 2002-05-28
KR100583065B1 (ko) 2006-06-08
ZA200006768B (en) 2001-11-20
HK1033271A1 (en) 2001-08-24
CN1186014C (zh) 2005-01-26

Similar Documents

Publication Publication Date Title
BR9910606A (pt) Forma farmacêutica multiparticular com liberação programada e pulsada e seu processo de preparo
AU594392B2 (en) Pharmaceutical preparation
Lankalapalli et al. Polyelectrolyte complexes: A review of their applicability in drug delivery technology
US4656027A (en) Pharmaceutical mixture
RS49629B (sr) Farmaceutska formulacija omeprazola
BG66251B1 (bg) Метод за получаване на формувани тела от (мет)акрилатни кополимери чрез леене под налягане
BR0013720A (pt) Formulação em pelota de liberação controlada
LV12602A (en) Enteric coated pharmaceutical composition and method of manufacturing
KR870000920A (ko) 9-데옥소-11-데옥시-9,11-[이미노[2-(2-메톡시에톡시) 에틸리덴]-옥시]-(9s)-에리트로마이신을 함유하는 경구투여용 고형 약제학적 제제의 제조방법
KR890000082A (ko) 서방성 제제 및 그의 제조방법
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
CY1106299T1 (el) Διepγασια για την παρασκευη στοματικων συνθεσεων ασβεστιων
SE0001151D0 (sv) Method for producing a controlled-release composition
DK0768870T3 (da) Multipel indkapsling af oleofile substanser
KR960021061A (ko) 경구 투여용 약제학적 조성물
Shen et al. Tetracycline release from tripolyphosphate–chitosan cross‐linked sponge: a preliminary in vitro study
ATE23266T1 (de) Pharmazeutische produkte in formen mit verzoegerter abgabe und verfahren an deren herstellung.
DK1417960T3 (da) Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
RU2256440C2 (ru) Фармацевтический препарат
CA2194216A1 (en) Carbamazepine medicament with retarded active substance release
ES2032125T3 (es) Forma galenica para la liberizacion prolongada del diltiazem.
Raysing et al. Formulation development and evaluation of novel dual-compartment capsule for stomach specific drug delivery
RU2001134166A (ru) Гранулирование расплава
TH60768A (th) การเตรียมยาปฏิชีวนะควิโนโลนชนิดปลดปล่อยแบบออกฤทธิ์เนิ่นและวิธีการสำหรับการเตรียมของมัน
TH72172B (th) การเตรียมยาปฏิชีวนะควิโนโลนชนิดปลดปล่อยแบบออกฤทธิ์เนิ่นและวิธีการสำหรับการเตรียมของมัน

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: LABORATOIRES DES PRODUITS ETHIQUES ETHYPHARM S.A. (FR)

B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/16, A61K 9/52, A61K 9/54, A61P 9/10

Ipc: A61K 9/54 (2009.01)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements